Ligandal is Drug Discovery in United States that focus on genetic materials business. Founded in 2013. They cover business area such as developer, nanomedicine therapy, gene editing tool, non-viral nano-carrier, gene-relate disease, peptide-base technology, gene therapy, regenerative medicine, immunotherapy, advanced antidote-vaccine technology genetic material, gene-specific payload, unprecedented precision, patient, relief.
2013
( 11 years old in 2024 )
Genetic Materials
-
650 5th Street
Suite 311
San Francisco, CA 94107
United States
Private
developernanomedicine therapygene editing toolnon-viral nano-carriergene-relate diseasepeptide-base technologygene therapyregenerative medicineimmunotherapyadvanced antidote-vaccine technology genetic materialgene-specific payloadunprecedented precisionpatientrelief
* We use standard office opening hours in near Ligandal's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Ligandal is Drug Discovery business from United States that founded in 2013 (11 years old in 2024), Ligandal business is focusing on Genetic Materials.
Ligandal headquarter office and corporate office address is located in 650 5th Street Suite 311 San Francisco, CA 94107 United States.
Ligandal was founded in United States.
In 2024, Ligandal is currently focus on genetic materials sector.
Above is snippet of Google Trends for "genetic materials" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Ligandal, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
